We are live on
!
Find out more
William Blair & Company Portfolio holdings
AUM
$38.4B
1-Year Est. Return
25.71%
This Fund
S&P 500
This Quarter
Est. Return
+9.7%
1 Year Est. Return
+25.71%
3 Year Est. Return
+88.7%
5 Year Est. Return
+104.53%
10 Year Est. Return
+665.86%
AUM
$27.3B
AUM Growth
+$2.26B
(+9%)
Cap. Flow
+$202M
Cap. Flow
% of AUM
0.74%
Top 10 Holdings %
Top 10 Hldgs %
24.36%
Holding
1,897
New
97
Increased
682
Reduced
737
Closed
88
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$28.3M |
| 2 |
Allstate
ALL
|
+$25.8M |
| 3 |
Intuitive Surgical
ISRG
|
+$19.6M |
| 4 |
Neogen
NEOG
|
+$17.4M |
| 5 |
DoubleVerify
DV
|
+$17.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Neurocrine Biosciences
NBIX
|
+$29.1M |
| 2 |
Planet Fitness
PLNT
|
+$20.4M |
| 3 |
Airbnb
ABNB
|
+$17.1M |
| 4 |
IBM
IBM
|
+$14.8M |
| 5 |
Xometry
XMTR
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.59% |
| 2 | Healthcare | 18.44% |
| 3 | Industrials | 11.64% |
| 4 | Financials | 11.51% |
| 5 | Consumer Discretionary | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Schwab US Large- Cap ETF
SCHX
$75B
| $706K | ﹤0.01% |
40,452
+6,288
| +18% | +$104K |
|
|
MTTR
952
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $697K | ﹤0.01% |
221,138
| – | – |
|
|
NATI
953
DELISTED
National Instruments Corp
NATI
| $694K | ﹤0.01% |
12,090
-10,596
| -47% | -$607K |
|
954
iShares 0-1 Year Treasury Bond ETF
SHV
$20.6B
| $694K | ﹤0.01% |
6,282
+4,870
| +345% | +$537K |
|
|
AUGX
955
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $694K | ﹤0.01% |
144,197
-30,400
| -17% | -$105K |
|
956
VSE Corp
VSEC
$6.48B
| $691K | ﹤0.01% |
12,632
+1,354
| +12% | +$65.5K |
|
957
Braze
BRZE
$3.36B
| $687K | ﹤0.01% |
15,682
-159
| -1% | -$5.4K |
|
958
ProShares Ultra Semiconductors
USD
$2.99B
| $685K | ﹤0.01% |
64,900
-9,900
| -13% | -$79.3K |
|
959
Lennar Class B
LEN.B
$20.7B
| $680K | ﹤0.01% |
6,331
+20
| +0.3% | +$1.88K |
|
960
Dollar General
DG
$26.9B
| $680K | ﹤0.01% |
4,002
+3
| +0.1% | +$593 |
|
961
Alphatec Holdings
ATEC
$1.51B
| $676K | ﹤0.01% |
37,575
| – | – |
|
962
Casella Waste Systems
CWST
$5.79B
| $675K | ﹤0.01% |
7,467
-53
| -0.7% | -$4.73K |
|
963
Western Digital
WDC
$168B
| $675K | ﹤0.01% |
23,543
-2,298
| -9% | -$63.9K |
|
964
Leonardo DRS
DRS
$11.9B
| $674K | ﹤0.01% |
38,850
+900
| +2% | +$13.9K |
|
965
Old Republic International
ORI
$10.3B
| $673K | ﹤0.01% |
26,731
-785
| -3% | -$19.7K |
|
966
Ionis Pharmaceuticals
IONS
$9.28B
| $672K | ﹤0.01% |
16,384
+1,740
| +12% | +$66.9K |
|
967
DraftKings
DKNG
$12.6B
| $670K | ﹤0.01% |
25,234
-2,295
| -8% | -$52.9K |
|
968
argenx
ARGX
$53.6B
| $670K | ﹤0.01% |
1,720
+675
| +65% | +$265K |
|
|
CTRA
969
DELISTED
Coterra Energy
CTRA
| $668K | ﹤0.01% |
26,403
+7,433
| +39% | +$185K |
|
970
NiSource
NI
$20.2B
| $668K | ﹤0.01% |
24,406
+200
| +0.8% | +$5.55K |
|
971
Innovator US Equity Power Buffer ETF March
PMAR
$771M
| $667K | ﹤0.01% |
19,761
+785
| +4% | +$25.7K |
|
972
Trade Desk
TTD
$6.84B
| $667K | ﹤0.01% |
8,633
+812
| +10% | +$54.9K |
|
973
GCM Grosvenor
GCMG
$2.85B
| $660K | ﹤0.01% |
87,595
+8,209
| +10% | +$61.2K |
|
974
ePlus
PLUS
$2.31B
| $655K | ﹤0.01% |
11,642
+353
| +3% | +$17.4K |
|
975
Impact Shares NAACP Minority Empowerment ETF
NACP
$77.7M
| $650K | ﹤0.01% |
20,540
-956
| -4% | -$28.5K |
|
Similar funds
HF
William Blair & Company's Q2 2023 Portfolio in Review
As of Q2 2023, William Blair & Company held 1,897 positions worth $27.3B, up 9% from $25B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
William Blair & Company's Q2 2023 filing shows 97 new, 682 increased, 737 reduced and 88 closed positions. Its largest new stake was Innovator US Equity Power Buffer ETF April: 112,249 shares worth $3.47M. The largest sale was Neurocrine Biosciences, an estimated $29.1M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Industrials.
- William Blair & Company's largest Q2 2023 buy was Innovator US Equity Power Buffer ETF April: 112,249 shares worth $3.47M.
- William Blair & Company added most to Costco in Q2 2023, an estimated $28.3M increase.
- William Blair & Company's biggest Q2 2023 reduction was Neurocrine Biosciences, cutting an estimated $29.1M.
- William Blair & Company fully exited ABB Ltd in Q2 2023, selling an estimated $7.21M.
- William Blair & Company's ten largest holdings make up 24% of its $27.3B portfolio in Q2 2023.
- William Blair & Company opened 97 new positions and closed 88 in Q2 2023.
- William Blair & Company's portfolio value rose 9% quarter-over-quarter to $27.3B.
Based on William Blair & Company's 13F filing for Q2 2023, filed 11 Aug 2023.